I’m 50 and have been using CJC-1295+Ipamorelin Combo for almost 1 year now. Yes with 2 rest periods. Very very happy with the results. Skin is smoother / softer to touch reduced bags under my eyes, my wife loves the new feel. I train 5 days a week and the increase in muscle volume and tone is very noticeable. I will say however it is a slow steady natural looking increase. Recovery is great and I think it is helping with injury repair, as i have a problem Knee that is feeling alot better ever since I’ve been on this product. As you can see the cost is high but if there were no outstanding results my wife would say I was a Di#*head, but she is encouraging me to continue. Train hard, eat well and look better. Use CJC-1295+Ipamorelin Combo. I do
Background: The human growth hormone (hGH) has properties making it a potential candidate to treat obesity, however safety issues limit its long-term use. AOD9604 is a peptide fragment of the C-terminus of hGH (Tyr-hGH177-191), which harbors the fat reducing activity of hGH, without its negative effects. In this paper the safety data of AOD9604 obtained in clinical trials are summarized.
An important component of losing weight and staying healthy is being active-whether by going to the gym or even just walking regularly. To stay active, we need to make sure our bodies stay strong, as well as avoid injuries or other aches and pains that may prevent us from working out. Collagen supplementation can help. Adding collagen protein into your daily diet can help support your bones and joints. In a 24-week study, researchers observed the effect of collagen hydrolysate supplementation on exercise related joint pain on 97 human athletes. The researchers found that collagen supplementation can reduce joint pain (3). Therefore, adding collagen into your daily routine can help in your weight loss plan by preventing pain and joint injury arising from physical activity and exercise.
Obesity affects as many as one in five adults in developed countries. Metabolic estimates that the potential worldwide market for effective obesity drugs is as much as $20 billion, far more than the current market of $1.5 billion. This is partly due to the potential need for chronically obese people to take obesity drugs such as AOD9604 and also because patients are put off using currently available drugs because of their marginal efficacy or side-effects.